Personalized Dendritic Cell Vaccines-Recent Breakthroughs and Encouraging Clinical Results

A Potential Antitumor Effect of Dendritic Cells Fused with Cancer Stem Cells in Hepatocellular Carcinoma

New treatment modalities with vaccine therapy in renal cell carcinoma

Hypomethylating agent alters the immune microenvironment in acute myeloid leukaemia (AML) and enhances the immunogenicity of a dendritic cell/AML vaccine

Randomized phase II trial of patient-specific dendritic cell vaccines loaded with autologous tumor antigens versus autologous monocytes in patients with primary advanced ovarian cancer.

Biologics, Immunotherapy, and Future Directions in the Treatment of Advanced Cholangiocarcinoma